Scancell utilises nanotechnology to amp up solid tumour vaccine
Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.
Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.
Cryoport acquires Cryogene to gain access to the latter company’s 21,000-square-foot biostorage facility in Houston.
WuXi Vaccines will build a dedicated manufacturing facility for an unnamed global vaccine leader, under a 20-year contract.
The Senate has passed a bill authorising spending on the development of products to protect the US against pandemic influenza and other biological threats to public health.